Proximo Medical, LLC today announced a partnership with PEDRA™ Technology, a Singapore based medical device innovator focused on the treatment of peripheral artery disease (PAD), for marketing and commercialization of its perfusion monitoring technology.
Proximo Medical is a fractional commercial organization for start-up medical device technologies and international medical device companies wishing to enter the U.S. market. The company provides market validation, an experienced national sales team and scalability to deliver patients and physicians the best care in a cost-effective model.
“Physicians and their industry partners have directed significant resources to determining the optimal treatment for patients with PAD, be it a balloon, a stent or another treatment. Far less time has been spent asking the question “Has the treatment I have chosen for this individual patient really improved outcomes”? The reason for this was that we did not have an easy-to-use, real-time method for assessing the quality of the intervention. PEDRA Technology has developed a new device that could possibly revolutionize the management of patients with PAD,” states Paul Hayes, vascular surgeon, Addenbrookes Hospital, Cambridge, United Kingdom, and lead investigator of the first-in-man study of the technology.